Proteomics International Developing Protein Biomarker-Based Diagnostic for Diabetic Nephropathy
October 08, 2010
Proteomics International Developing Protein Biomarker-Based Diagnostic for Diabetic Nephropathy
The company presented a panel of 13 biomarkers for the disease at last month's Human Proteome Organization annual meeting and is looking for partners and funding to develop it as a commercial diagnostic.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Proteomics International Wins $1M Grant to Develop Protein Test for Diabetic Nephropathy
August 24, 2012 / ProteoMonitor - Phosphoproteomic Screens Elucidate Feedback Loop Linked to mTOR Inhibitor Resistance
June 17, 2011 / ProteoMonitor - Expanded Proximity Ligation Assay Could Prove Valuable for Biomarker Studies, Top-Down Proteomics
May 13, 2011 / ProteoMonitor - MIT, Harvard Team Builds Nanosensor for Monitoring Cumulative Biomarker Exposure
February 18, 2011 / ProteoMonitor - ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor